When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Infecção por Chlamydia pneumoniae

  • Visão geral
  • Teoria
  • Diagnóstico
  • Tratamento
  • ACOMPANHAMENTO
  • Recursos
Last reviewed: 14 Aug 2025
Last updated: 25 Oct 2022

Summary

Definition

History and exam

Key diagnostic factors

  • presença de fatores de risco
Full details

Other diagnostic factors

  • doença em outros membros da família
  • tosse
  • febre
  • cefaleia
  • estertores
  • sibilos à ausculta torácica
  • taquipneia
  • dor torácica pleurítica
  • macicez à percussão/entrada de ar reduzida/frêmito tátil diminuído
Full details

Risk factors

  • superlotação
Full details

Diagnostic investigations

1st investigations to order

  • radiografia torácica
  • contagem diferencial de leucócitos
Full details

Investigations to consider

  • cultura de C pneumoniae da nasofaringe, do escarro ou do líquido pleural
  • anticorpo contra C pneumoniae
  • Testes de amplificação de ácido nucleico para C pneumoniae
Full details

Treatment algorithm

ACUTE

adultos

crianças

Contributors

Authors

Margaret R. Hammerschlag, MD

Professor of Pediatrics and Medicine

Director

Division of Pediatric Infectious Diseases

SUNY Downstate Medical Center

Brooklyn

NY

Disclosures

MRH is an author of a number of references cited in this monograph.

Peer reviewers

Yuji Oba, MD, FCCP

Associate Professor of Clinical Medicine

Division of Pulmonary/Critical Care Medicine

School of Medicine

University of Missouri-Columbia

Columbia

MO

Disclosures

YO declares that he has no competing interests.

Sebastian Johnston, MB, BS, PhD, FRCP

Professor of Respiratory Medicine

Honorary Consultant Physician in Allergy and Respiratory Medicine

Department of Respiratory Medicine

Imperial College School of Medicine

London

UK

Disclosures

SJ has received fees for speaking, and research and consultant fees from Sanofi Pasteur, Aventis, GlaxoSmithKline, AstroZeneca, Merck, Pfizer, Centocor, and Synergen.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis. 2007 Feb 15;44(4):568-76.Full text  Abstract

Rockey DD, Lenart J, Stephens RS. Genome sequencing and our understanding of Chlamydiae. Infect Immun. 2000 Oct;68(10):5473-9.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Infecção por Chlamydia pneumoniae images

  • Differentials

    • Doença do coronavírus 2019 (COVID-19)
    • Pneumonia por Mycoplasma pneumoniae
    • Pneumonia bacteriana
    More Differentials

  • Guidelines

    • Diagnosis and treatment of adults with community-acquired pneumonia
    More Guidelines

  • Patient information

    Pneumonia

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer